IN2013MU03310A - - Google Patents

Info

Publication number
IN2013MU03310A
IN2013MU03310A IN3310MU2013A IN2013MU03310A IN 2013MU03310 A IN2013MU03310 A IN 2013MU03310A IN 3310MU2013 A IN3310MU2013 A IN 3310MU2013A IN 2013MU03310 A IN2013MU03310 A IN 2013MU03310A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
sulbactam
imipenem
disclosed
Prior art date
Application number
Inventor
Sachin Bhagwat
Swapna Shripad Takalkar
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3310MU2013 priority Critical patent/IN2013MU03310A/en
Priority to US15/030,005 priority patent/US20160310472A1/en
Priority to EP14802501.8A priority patent/EP3060212A1/en
Priority to PCT/IB2014/065496 priority patent/WO2015059629A1/en
Publication of IN2013MU03310A publication Critical patent/IN2013MU03310A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Pharmaceutical compositions comprising sulbactam or a pharmaceutically acceptable derivative thereof, and imipenem or a pharmaceutically acceptable derivative thereof are disclosed.
IN3310MU2013 2013-10-22 2014-10-21 IN2013MU03310A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN3310MU2013 IN2013MU03310A (en) 2013-10-22 2014-10-21
US15/030,005 US20160310472A1 (en) 2013-10-22 2014-10-21 Pharmaceutical compositions comprising sulbactam and imipenem
EP14802501.8A EP3060212A1 (en) 2013-10-22 2014-10-21 Pharmaceutical compositions comprising sulbactam and imipenem
PCT/IB2014/065496 WO2015059629A1 (en) 2013-10-22 2014-10-21 Pharmaceutical compositions comprising sulbactam and imipenem

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3310MU2013 IN2013MU03310A (en) 2013-10-22 2014-10-21

Publications (1)

Publication Number Publication Date
IN2013MU03310A true IN2013MU03310A (en) 2015-07-31

Family

ID=51947405

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3310MU2013 IN2013MU03310A (en) 2013-10-22 2014-10-21

Country Status (4)

Country Link
US (1) US20160310472A1 (en)
EP (1) EP3060212A1 (en)
IN (1) IN2013MU03310A (en)
WO (1) WO2015059629A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129382B (en) * 2006-08-25 2013-12-25 天津和美生物技术有限公司 Antibiotic compound containing beta-lactam antibiotic and buffering component
FR2955028B1 (en) * 2010-01-13 2012-03-02 Centre Nat Rech Scient TREATMENT OF CHLAMYDIACEAE INFECTIONS BY BETA-LACTAMES
CN102349896B (en) * 2011-07-22 2013-03-27 广州定慧医药科技有限公司 Pharmaceutical composition of imipenem, cilastatin and sulbactam
KR101738210B1 (en) * 2011-07-26 2017-05-19 욱크하르트 리미티드 - pharmaceutical compositions comprising betalactam antibiotic sulbactam and betalactamase inhibitor

Also Published As

Publication number Publication date
US20160310472A1 (en) 2016-10-27
EP3060212A1 (en) 2016-08-31
WO2015059629A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
MX2020005181A (en) Aminopyridine derivatives as tam family kinase inhibitors.
EP3082817A4 (en) Compositions for drug administration
EP3129048A4 (en) Antibodies, pharmaceutical compositions and uses thereof
IL243627A0 (en) High potency pancreatin pharmaceutical compositions
TW201144301A (en) Processes for preparing linezolid
IL284419A (en) High potency pancreatin pharmaceutical compositions
EP3731832A4 (en) Cannabidiol dosage form
MX2016008369A (en) Pharmaceutical composition containing palonosetron.
EP3048103A4 (en) Immune adjustment compound, use thereof and pharmaceutical composition comprising same
IL252897A0 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
MX2017001487A (en) Sofosbuvir in crystalline form and process for its preparation.
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
IN2013MU01985A (en)
MX363631B (en) COMPOSITIONS and METHODS FOR TREATING BACTERIAL INFECTIONS.
HK1213810A1 (en) Nsaid administration and related compositions, methods and systems nsaid
IL238851A0 (en) Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
EP3190129A4 (en) Centrally-acting peptide derivative, and pharmaceutical composition
PH12017500071A1 (en) Therapeutic agent for keratoconjunctive disorder
IN2013MU03422A (en)
IN2014MU00859A (en)
IN2013MU03308A (en)
IN2013MU03310A (en)
GEP20196989B (en) Pharmaceutical composition comprising bisoprolol and perindoril
IN2013MU02015A (en)